C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. annual/quarterly total liabilities history from 2021 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- C4 Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 102.5M, a 23.30% decrease year-over-year.
- C4 Therapeutics Inc. total liabilities for 2025 were 102.5M, a 23.30% decrease from 2024.
- C4 Therapeutics Inc. total liabilities for 2024 were 133.6M, a 2.52% increase from 2023.
- C4 Therapeutics Inc. total liabilities for 2023 were 130.3M, a 7.96% decrease from 2022.
- C4 Therapeutics Inc. total liabilities for 2022 were 141.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| C4 Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $102 |
| 2024 | $134 |
| 2023 | $130 |
| 2022 | $142 |
| 2021 | $117 |
| C4 Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $102 |
| 2024-12-31 | $134 |
| 2023-12-31 | $130 |
| 2022-12-31 | $142 |
| 2021-12-31 | $117 |
C4 Therapeutics Inc. Total Liabilities — FAQ
C4 Therapeutics Inc. (CCCC) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's total liabilities history?
The chart and table above show C4 Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.